Pharmaceutical manufacturers face mounting pressure from volatile demand, complex therapies, stringent regulations and sustainability mandates, while over 60% of drug shortages stem from quality issues. Traditional manual workflows, paper-based systems and fragmented data create unacceptable operational risk in an industry where patent windows are narrow and regulatory scrutiny is intensifying.
To address these pressures, leading pharmaceutical companies are accelerating Digital Transformation across their manufacturing networks. Smart manufacturing connects the digital and physical worlds, enabling manufacturers to orchestrate operations with greater predictability, efficiency and confidence.
Modern Manufacturing Operations Management (MOM) platforms like Siemens Opcenter unify production, quality, planning and supply chain operations into a single validated ecosystem. These components define the core capabilities required for smart manufacturing for pharmaceuticals:
By embracing MOM as the core of smart manufacturing, pharmaceutical manufacturers can:
Discover how pharmaceutical manufacturers can leverage MOM to navigate complexity, strengthen quality and build future-ready operations. Download our ebook today.